We will be performing site maintenance on AAOS.org on April 8th, 2025, from 8:00 AM – 9:00 AM CST, which may cause sitewide downtime. We apologize for the inconvenience.
Alan M. Reznik, MD, MBA, FAAOS
Editor’s note: This is the sixth article in a series on artificial intelligence (AI) applications in orthopaedics and the future of medicine. This article discusses the ability to understand the “thought” process of AI and strategies required to make AI decision-making more transparent. The prior articles have reviewed the basics of AI, how AI can read an X-ray, natural language processing, medical ethics, and the differences between shallow and deep AI as it applies to the practice of medicine.
AAOS’ strategic investment in orthobiologics is well underway, overseen by the Committee on Devices, Biologics, and Technology (DBT) and the Council of Research and Quality, with goals to lay a strong, sustainable foundation in 2020, focusing resources toward creating unbiased, evidence-based content, while providing helpful and meaningful position statements, educational programs, regulatory resources, and symposia.
David C. Ring, MD, PhD, FAAOS, led a roundtable discussion to address patient cognitive error and bias and how they can impact illness, such as increasing the intensity of symptoms and creating a greater magnitude of limitations.
Some AAOS Now articles are available only to AAOS members. Please log in to access this article.
Not a member? Become a member.